CN101781314B - 左氧氟沙星半水物的制备工艺 - Google Patents
左氧氟沙星半水物的制备工艺 Download PDFInfo
- Publication number
- CN101781314B CN101781314B CN2010101185666A CN201010118566A CN101781314B CN 101781314 B CN101781314 B CN 101781314B CN 2010101185666 A CN2010101185666 A CN 2010101185666A CN 201010118566 A CN201010118566 A CN 201010118566A CN 101781314 B CN101781314 B CN 101781314B
- Authority
- CN
- China
- Prior art keywords
- levofloxacin
- ether
- hemihydrate
- ethylene glycol
- gram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 47
- SUIQUYDRLGGZOL-RCWTXCDDSA-N levofloxacin hemihydrate Chemical compound O.C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1.C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 SUIQUYDRLGGZOL-RCWTXCDDSA-N 0.000 title claims abstract description 36
- 229960003376 levofloxacin Drugs 0.000 claims abstract description 68
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 claims abstract description 58
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 54
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims abstract description 53
- -1 ethylene glycol monoalkyl ether Chemical class 0.000 claims abstract description 30
- 238000001035 drying Methods 0.000 claims abstract description 15
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000012046 mixed solvent Substances 0.000 claims abstract description 12
- NVKWWNNJFKZNJO-YFKPBYRVSA-N Ofloxacin impurity a Chemical compound N1([C@@H](C)CO2)C=C(C(O)=O)C(=O)C3=C1C2=C(F)C(F)=C3 NVKWWNNJFKZNJO-YFKPBYRVSA-N 0.000 claims abstract description 6
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000006243 chemical reaction Methods 0.000 claims description 20
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 16
- 238000005516 engineering process Methods 0.000 claims description 14
- 238000002425 crystallisation Methods 0.000 claims description 12
- 230000008025 crystallization Effects 0.000 claims description 12
- 238000001291 vacuum drying Methods 0.000 claims description 12
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 claims description 8
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 claims description 7
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical group COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims description 6
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- RMGHERXMTMUMMV-UHFFFAOYSA-N 2-methoxypropane Chemical compound COC(C)C RMGHERXMTMUMMV-UHFFFAOYSA-N 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- HIIBZFKVMXEQMR-UHFFFAOYSA-N 2-methyl-1-propan-2-yloxypropane Chemical compound CC(C)COC(C)C HIIBZFKVMXEQMR-UHFFFAOYSA-N 0.000 claims description 2
- 238000000967 suction filtration Methods 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 16
- 239000002904 solvent Substances 0.000 abstract description 16
- 238000000034 method Methods 0.000 abstract description 6
- 239000003960 organic solvent Substances 0.000 abstract description 5
- 239000002131 composite material Substances 0.000 abstract 1
- 238000006482 condensation reaction Methods 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 51
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- 238000003756 stirring Methods 0.000 description 27
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 23
- 238000011084 recovery Methods 0.000 description 19
- 238000010438 heat treatment Methods 0.000 description 18
- 238000009413 insulation Methods 0.000 description 18
- 238000010992 reflux Methods 0.000 description 18
- 230000003068 static effect Effects 0.000 description 18
- 239000013078 crystal Substances 0.000 description 14
- 229960001701 chloroform Drugs 0.000 description 12
- 238000000605 extraction Methods 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 230000006837 decompression Effects 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 239000010410 layer Substances 0.000 description 9
- 239000012044 organic layer Substances 0.000 description 9
- 235000011121 sodium hydroxide Nutrition 0.000 description 9
- 239000003643 water by type Substances 0.000 description 9
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 238000001953 recrystallisation Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000002351 wastewater Substances 0.000 description 3
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 150000005826 halohydrocarbons Chemical class 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 230000036228 toxication Effects 0.000 description 2
- HCGFUIQPSOCUHI-UHFFFAOYSA-N 2-propan-2-yloxyethanol Chemical compound CC(C)OCCO HCGFUIQPSOCUHI-UHFFFAOYSA-N 0.000 description 1
- XNIVKSPSCYJKBL-UHFFFAOYSA-N 2h-1,2-benzoxazine-6-carboxylic acid Chemical compound O1NC=CC2=CC(C(=O)O)=CC=C21 XNIVKSPSCYJKBL-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- LQEJKDNALLXRCT-UHFFFAOYSA-N chloroform;toluene Chemical compound ClC(Cl)Cl.CC1=CC=CC=C1 LQEJKDNALLXRCT-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- QQVIHTHCMHWDBS-UHFFFAOYSA-N perisophthalic acid Natural products OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000634 powder X-ray diffraction Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001757 thermogravimetry curve Methods 0.000 description 1
Images
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101185666A CN101781314B (zh) | 2010-03-05 | 2010-03-05 | 左氧氟沙星半水物的制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101185666A CN101781314B (zh) | 2010-03-05 | 2010-03-05 | 左氧氟沙星半水物的制备工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101781314A CN101781314A (zh) | 2010-07-21 |
CN101781314B true CN101781314B (zh) | 2012-03-14 |
Family
ID=42521477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101185666A Active CN101781314B (zh) | 2010-03-05 | 2010-03-05 | 左氧氟沙星半水物的制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101781314B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108218892A (zh) * | 2018-03-16 | 2018-06-29 | 乐山职业技术学院 | 一种左氧氟沙星的纯化方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7425628B2 (en) * | 2001-10-03 | 2008-09-16 | Teva Pharmaceutical Industries Ltd. | Methods for the purification of levofloxacin |
AU2003285625A1 (en) * | 2002-12-16 | 2004-07-09 | Ranbaxy Laboratories Limited | Pure levofloxacin hemihydrate and processes for preparation thereof |
JP2006111561A (ja) * | 2004-10-14 | 2006-04-27 | Ohara Yakuhin Kogyo Kk | 抗菌薬の1/2水和物の製造方法 |
CN101307060A (zh) * | 2008-07-04 | 2008-11-19 | 浙江京新药业股份有限公司 | 左氧氟沙星半水化合物的制备工艺 |
US7964723B2 (en) * | 2008-08-02 | 2011-06-21 | Apeloa-Kangyu | And practical process for exclusively producing (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido-[1,2,3,de][1,4]benzoxazine-6-carboxylic acid hemihydrate |
-
2010
- 2010-03-05 CN CN2010101185666A patent/CN101781314B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101781314A (zh) | 2010-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2726599A1 (en) | Process for treprostinil salt preparation | |
CN102143964A (zh) | 制备腺嘌呤化合物的方法 | |
CN101307060A (zh) | 左氧氟沙星半水化合物的制备工艺 | |
AU2022215237B2 (en) | Methods of preparing indolinobenzodiazepine derivatives | |
CN113087712A (zh) | L-氨基酸-6-胶霉毒素酯三氟乙酸盐及其制备方法 | |
CN101781314B (zh) | 左氧氟沙星半水物的制备工艺 | |
CN102952131B (zh) | 一种盐酸莫西沙星的制备方法 | |
CN105712919B (zh) | 酰胺缩合剂在维格列汀合成方法中的应用 | |
CN101328185B (zh) | 由1,3-二苄基4-烷氧基生物素中间体合成d-生物素的方法 | |
CN101863904A (zh) | 一种高纯度左氧氟沙星半水合物的制备方法 | |
AU2018256494B2 (en) | Method for the preparation of (1,2,4)-triazolo(4,3-A)pyridines | |
CN114890999B (zh) | 一种pqq的制备方法 | |
ES2314927T3 (es) | Procedimiento para la obtencion de un compuesto farmaceuticamente activo, sus intermedios de sintesis y procedimientos para la obtencion de los mismos. | |
Ho et al. | Inhibitors of Monoamine Oxidase III: 9-Substituted-β-Carbolines | |
CN101575344A (zh) | 高纯度假多晶型左氧氟沙星半水化合物的制备方法 | |
US20080269493A1 (en) | Crystalline forms of topotecan hydrochloride and processes for making the same | |
CZ20023723A3 (cs) | Způsob čištění soli klavulanové kyseliny | |
CN1544440A (zh) | 磷霉素单氨丁三醇合成新方法 | |
CN102516002A (zh) | 一种光学纯α-羟基酸及其衍生物的制备工艺 | |
SU525429A3 (ru) | Способ получени производных 3-оксииминометилцефалоспорина или их солей | |
ES2264901B1 (es) | Procedimiento para la obtencion de un compuesto farmaceuticamente activo, sus intermedios de sintesis y procedimiento para la obtencion de los mismos. | |
EP1844041A4 (en) | IMPROVED PROCESS FOR THE PREPARATION OF MYCOPHENOLATE MOFETIL | |
CN116354962A (zh) | 12位氮取代苦参酸酯衍生物、制备方法及其应用 | |
CN116354982A (zh) | 一种acc抑制剂的制备方法 | |
CN114751846A (zh) | 一种氟苯尼考的缬氨酸脂盐的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 312500, 800 Dadao East Road, Chengguan Town, Xinchang County, Shaoxing City, Zhejiang Province Patentee after: ZHEJIANG JINGXIN PHARMACEUTICAL Co.,Ltd. Country or region after: China Patentee after: Shaoxing Jingxin Pharmaceutical Co.,Ltd. Address before: 312500, 800 Dadao East Road, Chengguan Town, Xinchang County, Shaoxing City, Zhejiang Province Patentee before: ZHEJIANG JINGXIN PHARMACEUTICAL Co.,Ltd. Country or region before: China Patentee before: SHANGYU JINGXIN PHARMACEUTICAL Co.,Ltd. |